[Acute hepatitis and pneumonitis associated with nitrofurantoin]

A Kursbaum1, E Rottenstreich

  • 1Dept. of Medicine, Zevulun Clinic, Kiryat Motzkin.

Harefuah
|December 16, 1990
PubMed

Insights

Nitrofurantoin, used for urinary tract infections, can cause severe side effects like liver damage and lung inflammation. Regular monitoring is crucial when prescribing this antibiotic to detect potential adverse reactions early.

Area of Science:

  • Pharmacology
  • Toxicology
  • Infectious Diseases

Background:

  • Nitrofurantoin is a common antibiotic for urinary tract infections (UTIs).
  • While generally safe, it can cause adverse effects, ranging from mild gastrointestinal issues to severe organ damage.
  • Severe side effects include pulmonary reactions, liver damage, blood disorders, and neuropathy.

Observation:

  • This report details a case of acute hepatic injury and pneumonitis.
  • The patient experienced adverse reactions attributed to nitrofurantoin use.

Findings:

  • Nitrofurantoin is an infrequent but serious cause of liver injury.
  • The drug's hepatic toxicity spectrum includes acute hepatocellular/cholestatic injury and chronic active hepatitis.
  • Concurrent pneumonitis was observed in this case.

Implications:

  • Healthcare providers should be aware of nitrofurantoin's potential for severe hepatic and pulmonary toxicity.
  • Periodic clinical and laboratory monitoring is essential during nitrofurantoin therapy.
  • Early detection and intervention can mitigate severe adverse events associated with nitrofurantoin.

Related Concept Videos

2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...